Dr. Meshinchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N
Seattle, WA 98109Phone+1 206-667-4077- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 1997 - 2000
- Johns Hopkins UniversityResidency, Pediatrics, 1994 - 1997
- Wayne State University School of MedicineClass of 1994
- University of MichiganPh.D., Pharmacology, 1985 - 1990
- The University of Michigan School of MedicinePh.D., 1985 - 1990
- Regents of The University of Michigan - Regional Alliance for HEAB.S., Microbiology, 1980 - 1984
Certifications & Licensure
- WA State Medical License 1998 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2010 Jan 01
- Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2010 Jan 01
- Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia Start of enrollment: 2010 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.Oussama Abla, Rhonda E Ries, Tim Triche Jr, Robert B Gerbing, Betsy Hirsch, Susana Raimondi, Todd Cooper, Jason E Farrar, Nathaniel Buteyn, Lauren M Harmon, Hong Wen, ...> ;Blood Advances. 2024 Apr 23
- Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David Frankhouser, Denis O'Meally, Ya-Huei Kuo, Russell Rockne, Nataly Kravchenko-Balasha, Soheil M...> ;NPJ Systems Biology and Applications. 2024 Mar 25
- Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.Lasky, J., Mullen, C., Angelucci, E., Vinti, L., Pemmaraju, N., Cuglievan, B., Kheradpour, A., Hijiya, N., Stein, A., Meshinchi, S., Mughal, T., Pawlowska, A.> ;Ejhaem. 2024 Feb 1
- Join now to see all
Journal Articles
- Acute Myeloid Leukemia in Children and Adolescents: Identification of New Molecular Targets Brings Promise of New TherapiesSoheil Meshinchi, MD, Hematology ASH Education Program
- Prognostic Impact of T(16;21)(p11;q22) and T(16;21)(q24;q22) in Pediatric AML: A Retrospective Study by the I-BFM Study GroupSoheil Meshinchi, Tanja A Gruber, Blood
- Pan-cancer Genome and Transcriptome Analyses of 1,699 Pediatric Leukemias and Solid TumorsMa X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, Zhou X, Li Y, Rusch MC, Easton J, Huether R, Gonzalez-Pena V, Wilkinson MR, Hermida LC, Davis S, Sioson E, Pou..., Nature Medicine, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic StrategiesSoheil Meshinchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene _ a COG/Tpaml StudySoheil Meshinchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous...Soheil Meshinchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML05312018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Signaling Responses to Stroma-Derived Soluble Factors Are Associated with Outcome and with Expression of Microenvironment-Related Genes in Pediatric AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Immunotherapeutic Targeting of Mesothelin in Acute Myeloid Leukemia in Vitro with Anetumab Ravtansine and a Novel Antibody-Drug Conjugate2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Computer Science Reveals Possible Drug Target for Deadly Childhood LeukemiaMarch 14th, 2023
- Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022December 10th, 2022
- BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric LeukemiaFebruary 28th, 2022
- Join now to see all
Hospital Affiliations
- Seattle Children's HospitalSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: